Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Elekta    EKTA B   SE0000163628

ELEKTA

(EKTA B)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Elekta : The underlying trend is to the upside

share with twitter share with LinkedIn share with facebook
share via e-mail
09/12/2019 | 08:34am EDT
long trade
Live
Entry price : 132.05SEK | Target : 155SEK | Stop-loss : 120SEK | Potential : 17.38%
Shares in Elekta show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Investors have an opportunity to buy the stock and target the SEK 155.
Chart ELEKTA
Duration : Period :
Elekta Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at SEK 123.4 SEK in weekly data.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The stock is in a well-established, long-term rising trend above the technical support level at 123.4 SEK

Weaknesses
  • The company's earnings releases usually do not meet expectations.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.74 times its estimated earnings per share for the ongoing year.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Subsector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
ELEKTA22.59%5 147
THERMO FISHER SCIENTIFIC33.00%119 202
DANAHER CORPORATION37.45%101 163
INTUITIVE SURGICAL9.25%60 303
BOSTON SCIENTIFIC CORPORATI..18.31%58 240
EDWARDS LIFESCIENCES CORPOR..43.30%45 649
ILLUMINA, INC.0.33%44 234
ROYAL PHILIPS39.64%43 019
SIEMENS HEALTHINEERS-3.04%39 219
SHENZHEN MINDRAY BIO-MEDL E..--.--%30 966
AGILENT TECHNOLOGIES14.99%24 108
Autres valeurs du secteur

Jordan Dufee
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (SEK)
Sales 2020 15 258 M
EBIT 2020 2 104 M
Net income 2020 1 523 M
Finance 2020 1 434 M
Yield 2020 1,41%
P/E ratio 2020 32,5x
P/E ratio 2021 25,8x
EV / Sales2020 3,15x
EV / Sales2021 2,82x
Capitalization 49 434 M
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 133,14  SEK
Last Close Price 129,40  SEK
Spread / Highest target 39,1%
Spread / Average Target 2,89%
Spread / Lowest Target -28,1%
EPS Revisions
Managers
NameTitle
Richard Hausmann President & Chief Executive Officer
Laurent Leksell Chairman
Steven Mark Wort Chief Operating Officer
Gustaf Salford Chief Financial Officer & Executive Vice President
John Lapré Chief Technology Officer